Scanfil Acquires SRX, Expanding its Presence in Asia Pacific
October 7, 2024 | ScanfilEstimated reading time: 1 minute
Scanfil has acquired SRXGlobal Pty Ltd. for EUR 23.3 million (USD 25.7 million), marking a key step in its Asia Pacific expansion. This acquisition includes SRX factories in Melbourne, Australia, and Johor Bahru, Malaysia, with 8 automated SMT lines and about 300 employees.
“The acquisition of SRX is a step in building up our presence in Asia Pacific region and the implementation of our strategy. It creates synergies in procurement, improves geographic diversification and strengthens our customer portfolio”, says Christophe Sut, CEO of Scanfil. “The acquisition brings us new customers and allows our existing customers to expand their operations with us in the new areas of the fast-growing Asia Pacific region. For SRX employees, a bigger and more international company creates new career and personal development opportunities. I want to welcome all our new employees to be part of the growing Scanfil family”.
“We have a lot in common with Scanfil with our Medical and Industrial focus, complex manufacturing capabilities and, importantly, genuine pride in the people we employ – creating a team that can deliver world class operational performance takes time and dedication” comments Paul Appleby, CEO of SRX. “For almost 30 years, SRX has provided exceptional service in Australia and Malaysia and developing meaningful relationships with our staff, customers, and suppliers. Culturally, we are very close to Scanfil and share similar values with high work ethic, professionalism in all things we do, and strong customer focus. I am thrilled that SRX is now part of the Scanfil family, and I look forward to seeing SRX grow stronger under the new ownership structure”.
Financial highlights show SRX’s robust performance, with turnovers of EUR 41,956,000 and EUR 39,009,000 for the years ending June 30, 2023, and June 30, 2024, respectively.
The EUR 23.3 million (USD 25.7 million) acquisition will be financed with Scanfil’s liquid assets. Additionally, the seller may earn up to EUR 10.5 million (USD 11.6 million) based on the financial performance of 2024 and 2025. The transaction has a minimal impact on Scanfil’s Net Debt/EBITDA ratio, staying below the target of 1.5x.
Scanfil’s financial outlook for 2024 remains unchanged.
Suggested Items
Worldwide Smartphone Market Forecast to Grow 6.2% in 2024, Fueled by Robust Growth for Android in Emerging Markets and China
11/27/2024 | IDCWorldwide smartphone shipments are forecast to grow 6.2% year-over-year in 2024 to 1.24 billion units, according to the latest International Data Corporation (IDC) Worldwide Quarterly Mobile Phone Tracker.
WSTS Semiconductor Market Forecast Spring 2024
11/26/2024 | WSTSWSTS has adjusted its Spring 2024 forecast upwards, projecting a 16.0 percent growth in the global semiconductor market compared to the previous year.
IPC Japan Puts More Focus on Collaboration, Standards Development, Advanced Packaging
11/26/2024 | Yusaku Kono, IPC Japan RepresentativeIn the past year, IPC has strengthened its relationships with key Japanese companies and government bodies. This was accomplished, in part, by a visit to Japan this past summer, where members of the IPC Asia team, punctuated by standards committee work last winter, forged stronger ties with government officials and companies involved in electronics manufacturing.
Global Notebook Shipments Expected to Grow by 4.9% in 2025, Business Demand Emerges as a Key Driver
11/25/2024 | TrendForceTrendForce reports that the global notebook market in 2024 is projected to recover at a moderate pace, hindered by high interest rates and geopolitical uncertainties.
Real Time with... electronica 2024: SPEA's AI Integration—Innovations in Test Equipment
11/25/2024 | Real Time with... electronicaIn this interview from electronica 2024, Pete Starkey speaks with Andrea Furnari, VP of Electronic Test Products Business Unit for SPEA. The discussion revolves around AI integration in test equipment, trends in substrate materials, and SPEA's focus on R&D.